Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

2.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

3.

Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.

Farahani P, Levine M, Gaebel K, Thabane L.

Can J Clin Pharmacol. 2005 Fall;12(3):e254-63. Epub 2005 Nov 7. Review.

PMID:
16278497
4.

Mechanism and clinical significance of wear debris-induced osteolysis.

Amstutz HC, Campbell P, Kossovsky N, Clarke IC.

Clin Orthop Relat Res. 1992 Mar;(276):7-18. Review.

PMID:
1537177
5.

Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.

Schwarz EM, Looney RJ, O'Keefe RJ.

Arthritis Res. 2000;2(3):165-8. Epub 2000 Mar 27. Review.

6.

Are biologic treatments a potential approach to wear- and corrosion-related problems?

Smith RL, Schwarz EM.

Clin Orthop Relat Res. 2014 Dec;472(12):3740-6. doi: 10.1007/s11999-014-3765-9. Review.

7.

The role of osteoblasts in peri-prosthetic osteolysis.

O'Neill SC, Queally JM, Devitt BM, Doran PP, O'Byrne JM.

Bone Joint J. 2013 Aug;95-B(8):1022-6. doi: 10.1302/0301-620X.95B8.31229. Review.

PMID:
23908414
8.

Current concepts in osteolysis.

Ollivere B, Wimhurst JA, Clark IM, Donell ST.

J Bone Joint Surg Br. 2012 Jan;94(1):10-5. doi: 10.1302/0301-620X.94B1.28047. Review.

PMID:
22219240
9.

Osteolysis: basic science.

Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT.

Clin Orthop Relat Res. 2001 Dec;(393):71-7. Review.

PMID:
11764373
10.

Potential use of erythromycin to prevent and treat prosthetic failure.

Zhang P, Qin L.

J Clin Pharmacol. 2010 Aug;50(8):858-60. doi: 10.1177/0091270009360535. Epub 2010 Feb 11. Review.

PMID:
20150525
11.

Report: Osteocyte enhancement function of bisphosphonates in prosthetic replacement.

Yang J, Wang S, Meng Q, Sun Y, Ran AF.

Pak J Pharm Sci. 2015 May;28(3 Suppl):1167-9. Review.

PMID:
26051741
12.

[Volume-outcome-relationship in total hip replacement--literature review and model calculation of the health care situation].

Schräder P, Rath T.

Z Orthop Unfall. 2007 May-Jun;145(3):281-90. Review. German.

PMID:
17607624
13.

Biological response to prosthetic debris.

Bitar D, Parvizi J.

World J Orthop. 2015 Mar 18;6(2):172-89. doi: 10.5312/wjo.v6.i2.172. eCollection 2015 Mar 18. Review.

14.

The Role of the Chemokine System in Tissue Response to Prosthetic By-products Leading to Periprosthetic Osteolysis and Aseptic Loosening.

Dyskova T, Gallo J, Kriegova E.

Front Immunol. 2017 Aug 24;8:1026. doi: 10.3389/fimmu.2017.01026. eCollection 2017. Review.

15.

Peri-prosthetic bone cysts after total ankle replacement. A systematic review and meta-analysis.

Arcângelo J, Guerra-Pinto F, Pinto A, Grenho A, Navarro A, Martin Oliva X.

Foot Ankle Surg. 2017 Nov 29. pii: S1268-7731(17)31347-4. doi: 10.1016/j.fas.2017.11.002. [Epub ahead of print] Review.

PMID:
29409184
16.

[Osteolysis].

Naritomi K.

Ryoikibetsu Shokogun Shirizu. 2001;(34 Pt 2):422-3. Review. Japanese. No abstract available.

PMID:
11528816

Supplemental Content

Support Center